| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Placenta | 108 | 2024 | 628 | 15.520 |
Why?
|
| Trophoblasts | 67 | 2023 | 165 | 10.770 |
Why?
|
| Fetal Growth Retardation | 41 | 2023 | 470 | 5.230 |
Why?
|
| Fetal Development | 30 | 2023 | 248 | 4.480 |
Why?
|
| Pregnancy | 150 | 2024 | 5499 | 4.150 |
Why?
|
| TOR Serine-Threonine Kinases | 38 | 2023 | 359 | 3.960 |
Why?
|
| Pregnancy Complications | 21 | 2020 | 430 | 3.650 |
Why?
|
| Maternal-Fetal Exchange | 25 | 2021 | 151 | 3.160 |
Why?
|
| Amino Acids | 22 | 2023 | 445 | 3.060 |
Why?
|
| Diabetes, Gestational | 20 | 2023 | 281 | 3.050 |
Why?
|
| Obesity | 26 | 2023 | 2505 | 2.530 |
Why?
|
| Docosahexaenoic Acids | 7 | 2023 | 69 | 2.200 |
Why?
|
| Birth Weight | 15 | 2022 | 439 | 2.060 |
Why?
|
| Insulin | 27 | 2023 | 2080 | 1.990 |
Why?
|
| Fatty Acids | 10 | 2024 | 380 | 1.970 |
Why?
|
| Amino Acid Transport System A | 15 | 2021 | 33 | 1.950 |
Why?
|
| Adiponectin | 14 | 2022 | 213 | 1.910 |
Why?
|
| Fetus | 12 | 2022 | 698 | 1.880 |
Why?
|
| Fatty Acids, Unsaturated | 4 | 2018 | 84 | 1.860 |
Why?
|
| Biological Transport | 29 | 2021 | 374 | 1.840 |
Why?
|
| Amino Acid Transport Systems | 16 | 2020 | 38 | 1.730 |
Why?
|
| Fetal Macrosomia | 12 | 2023 | 58 | 1.700 |
Why?
|
| Cell Membrane | 26 | 2020 | 670 | 1.600 |
Why?
|
| Female | 157 | 2024 | 59324 | 1.550 |
Why?
|
| Pregnancy in Diabetics | 8 | 2021 | 82 | 1.380 |
Why?
|
| Oleic Acid | 3 | 2014 | 30 | 1.360 |
Why?
|
| Phospholipids | 5 | 2024 | 194 | 1.350 |
Why?
|
| Signal Transduction | 36 | 2023 | 4501 | 1.320 |
Why?
|
| Pregnancy Trimester, First | 12 | 2020 | 125 | 1.290 |
Why?
|
| Folic Acid | 7 | 2021 | 161 | 1.290 |
Why?
|
| Body Mass Index | 14 | 2021 | 1957 | 1.280 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2023 | 122 | 1.230 |
Why?
|
| Insulin-Like Growth Factor I | 11 | 2023 | 286 | 1.210 |
Why?
|
| Carrier Proteins | 10 | 2021 | 694 | 1.210 |
Why?
|
| Microvilli | 20 | 2019 | 70 | 1.200 |
Why?
|
| Pregnancy Proteins | 5 | 2022 | 36 | 1.160 |
Why?
|
| Dietary Supplements | 5 | 2021 | 459 | 1.100 |
Why?
|
| Lysophosphatidylcholines | 3 | 2024 | 20 | 1.060 |
Why?
|
| Folate Receptor 1 | 4 | 2019 | 13 | 1.050 |
Why?
|
| Glucose Transporter Type 1 | 9 | 2023 | 43 | 1.050 |
Why?
|
| Humans | 134 | 2024 | 114045 | 0.980 |
Why?
|
| Phosphatidylcholines | 5 | 2024 | 132 | 0.950 |
Why?
|
| Palmitic Acid | 2 | 2014 | 37 | 0.950 |
Why?
|
| Fatty Acid Transport Proteins | 4 | 2018 | 18 | 0.940 |
Why?
|
| Glucose | 15 | 2022 | 899 | 0.890 |
Why?
|
| Symporters | 1 | 2023 | 52 | 0.880 |
Why?
|
| Fetal Blood | 6 | 2022 | 268 | 0.860 |
Why?
|
| Gene Expression Regulation | 10 | 2021 | 2322 | 0.860 |
Why?
|
| Reduced Folate Carrier Protein | 3 | 2019 | 8 | 0.850 |
Why?
|
| Adiposity | 5 | 2021 | 458 | 0.850 |
Why?
|
| Glucose Intolerance | 5 | 2022 | 137 | 0.840 |
Why?
|
| Insulin Resistance | 7 | 2022 | 1072 | 0.830 |
Why?
|
| Lipoprotein Lipase | 5 | 2018 | 54 | 0.820 |
Why?
|
| Prenatal Exposure Delayed Effects | 6 | 2022 | 453 | 0.820 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 12 | 2023 | 97 | 0.810 |
Why?
|
| Glycerol | 1 | 2022 | 84 | 0.800 |
Why?
|
| Multiprotein Complexes | 6 | 2015 | 140 | 0.800 |
Why?
|
| Lipids | 5 | 2022 | 564 | 0.800 |
Why?
|
| Cells, Cultured | 22 | 2020 | 3861 | 0.780 |
Why?
|
| Lipid Metabolism | 4 | 2018 | 441 | 0.770 |
Why?
|
| Adult | 48 | 2022 | 30375 | 0.760 |
Why?
|
| Infant, Newborn | 25 | 2022 | 5038 | 0.750 |
Why?
|
| Gestational Age | 21 | 2021 | 761 | 0.750 |
Why?
|
| Proton-Coupled Folate Transporter | 3 | 2019 | 8 | 0.740 |
Why?
|
| Hypoglycemic Agents | 3 | 2019 | 1011 | 0.730 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2022 | 397 | 0.730 |
Why?
|
| Preconception Care | 1 | 2021 | 30 | 0.720 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 9 | 2021 | 141 | 0.700 |
Why?
|
| Membrane Transport Proteins | 6 | 2023 | 138 | 0.680 |
Why?
|
| Amino Acid Transport System L | 7 | 2021 | 16 | 0.650 |
Why?
|
| Primary Cell Culture | 7 | 2019 | 148 | 0.640 |
Why?
|
| Triglycerides | 4 | 2022 | 467 | 0.640 |
Why?
|
| Fetal Nutrition Disorders | 3 | 2015 | 7 | 0.640 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2019 | 47 | 0.630 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 8 | 2023 | 55 | 0.620 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 3 | 2004 | 43 | 0.610 |
Why?
|
| Animals | 60 | 2023 | 31565 | 0.600 |
Why?
|
| PPAR alpha | 4 | 2015 | 52 | 0.590 |
Why?
|
| Phosphorylation | 11 | 2023 | 1558 | 0.590 |
Why?
|
| Arachidonic Acid | 2 | 2017 | 112 | 0.590 |
Why?
|
| Chromatography, Liquid | 3 | 2023 | 345 | 0.570 |
Why?
|
| alpha-Linolenic Acid | 1 | 2017 | 7 | 0.570 |
Why?
|
| Calcium | 6 | 2003 | 1089 | 0.570 |
Why?
|
| Placentation | 8 | 2021 | 40 | 0.570 |
Why?
|
| Glyburide | 1 | 2017 | 35 | 0.560 |
Why?
|
| CD36 Antigens | 2 | 2016 | 36 | 0.550 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2023 | 410 | 0.540 |
Why?
|
| Placental Insufficiency | 2 | 2019 | 102 | 0.540 |
Why?
|
| Chorionic Villi | 6 | 2019 | 16 | 0.540 |
Why?
|
| Ion Transport | 7 | 2009 | 54 | 0.530 |
Why?
|
| Coenzyme A Ligases | 1 | 2016 | 11 | 0.520 |
Why?
|
| Fatty Acid-Binding Proteins | 5 | 2018 | 60 | 0.500 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 445 | 0.500 |
Why?
|
| Gene Expression Regulation, Developmental | 6 | 2021 | 801 | 0.500 |
Why?
|
| STAT3 Transcription Factor | 3 | 2014 | 172 | 0.480 |
Why?
|
| Interleukin-1beta | 2 | 2014 | 368 | 0.460 |
Why?
|
| Blood Glucose | 8 | 2022 | 1827 | 0.460 |
Why?
|
| Labor, Obstetric | 1 | 2014 | 52 | 0.460 |
Why?
|
| Inflammation | 2 | 2015 | 2464 | 0.460 |
Why?
|
| Folic Acid Deficiency | 3 | 2021 | 48 | 0.460 |
Why?
|
| Papio | 6 | 2021 | 96 | 0.440 |
Why?
|
| Sodium | 13 | 2020 | 184 | 0.440 |
Why?
|
| Interleukin-6 | 3 | 2015 | 673 | 0.430 |
Why?
|
| Ceramides | 1 | 2014 | 91 | 0.430 |
Why?
|
| RNA, Small Interfering | 5 | 2023 | 534 | 0.430 |
Why?
|
| Leucine | 4 | 2020 | 102 | 0.410 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 186 | 0.400 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2015 | 1128 | 0.400 |
Why?
|
| Calcium-Transporting ATPases | 2 | 2003 | 34 | 0.390 |
Why?
|
| Mice | 21 | 2023 | 14843 | 0.390 |
Why?
|
| Fetal Weight | 6 | 2015 | 52 | 0.380 |
Why?
|
| PPAR gamma | 5 | 2022 | 182 | 0.380 |
Why?
|
| Pregnancy Trimester, Third | 5 | 2010 | 79 | 0.370 |
Why?
|
| Arachidonic Acids | 2 | 2022 | 56 | 0.360 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 2012 | 150 | 0.360 |
Why?
|
| Placental Circulation | 6 | 2019 | 56 | 0.360 |
Why?
|
| Blotting, Western | 10 | 2010 | 1143 | 0.350 |
Why?
|
| Extracellular Vesicles | 2 | 2022 | 83 | 0.350 |
Why?
|
| Pregnancy Trimester, Second | 2 | 2020 | 66 | 0.340 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 2087 | 0.340 |
Why?
|
| In Vitro Techniques | 15 | 2012 | 1003 | 0.330 |
Why?
|
| Down-Regulation | 8 | 2018 | 594 | 0.330 |
Why?
|
| Overweight | 4 | 2015 | 473 | 0.330 |
Why?
|
| RNA, Messenger | 9 | 2023 | 2550 | 0.330 |
Why?
|
| Fusion Regulatory Protein 1, Light Chains | 3 | 2020 | 6 | 0.330 |
Why?
|
| Monosaccharide Transport Proteins | 4 | 2004 | 45 | 0.320 |
Why?
|
| Term Birth | 3 | 2015 | 19 | 0.320 |
Why?
|
| Protein Kinases | 6 | 2019 | 304 | 0.320 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 5 | 2015 | 57 | 0.310 |
Why?
|
| Insulin Receptor Substrate Proteins | 3 | 2014 | 56 | 0.310 |
Why?
|
| Decidua | 2 | 2019 | 23 | 0.310 |
Why?
|
| Metabolic Diseases | 2 | 2020 | 98 | 0.310 |
Why?
|
| Immunity, Innate | 1 | 2014 | 720 | 0.310 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2012 | 285 | 0.300 |
Why?
|
| Immunohistochemistry | 9 | 2018 | 1624 | 0.300 |
Why?
|
| Young Adult | 10 | 2019 | 10444 | 0.290 |
Why?
|
| Male | 27 | 2023 | 55396 | 0.290 |
Why?
|
| Sex Characteristics | 2 | 2023 | 636 | 0.290 |
Why?
|
| Sodium-Hydrogen Exchangers | 3 | 2002 | 21 | 0.290 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 3 | 2023 | 24 | 0.290 |
Why?
|
| Case-Control Studies | 10 | 2021 | 3003 | 0.280 |
Why?
|
| Heart Diseases | 2 | 2022 | 329 | 0.280 |
Why?
|
| Hyperlipoproteinemia Type I | 1 | 2007 | 7 | 0.280 |
Why?
|
| Fatty Liver | 2 | 2022 | 209 | 0.280 |
Why?
|
| Endocrine Disruptors | 2 | 2018 | 34 | 0.270 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2006 | 19 | 0.270 |
Why?
|
| Hormones | 3 | 2017 | 132 | 0.270 |
Why?
|
| Myocardium | 6 | 2019 | 911 | 0.260 |
Why?
|
| Lipase | 2 | 2015 | 55 | 0.260 |
Why?
|
| Diet, Protein-Restricted | 2 | 2021 | 10 | 0.260 |
Why?
|
| Large Neutral Amino Acid-Transporter 1 | 3 | 2023 | 15 | 0.250 |
Why?
|
| AMP-Activated Protein Kinases | 5 | 2022 | 170 | 0.250 |
Why?
|
| Organ Size | 8 | 2018 | 434 | 0.240 |
Why?
|
| Cesarean Section | 3 | 2022 | 169 | 0.230 |
Why?
|
| Receptors, Adiponectin | 3 | 2019 | 15 | 0.230 |
Why?
|
| MAP Kinase Signaling System | 3 | 2019 | 271 | 0.230 |
Why?
|
| H(+)-K(+)-Exchanging ATPase | 1 | 2004 | 15 | 0.230 |
Why?
|
| Oxygen | 2 | 2022 | 851 | 0.230 |
Why?
|
| Ether | 1 | 2023 | 7 | 0.220 |
Why?
|
| Ethyl Ethers | 1 | 2023 | 4 | 0.220 |
Why?
|
| Plasmalogens | 1 | 2023 | 6 | 0.220 |
Why?
|
| Ethers | 1 | 2023 | 16 | 0.220 |
Why?
|
| Enzyme Activation | 3 | 2015 | 771 | 0.220 |
Why?
|
| Phosphatidylethanolamines | 1 | 2023 | 66 | 0.210 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2014 | 145 | 0.210 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2014 | 249 | 0.210 |
Why?
|
| Intracellular Membranes | 1 | 2003 | 73 | 0.210 |
Why?
|
| Embryonic Development | 2 | 2021 | 117 | 0.210 |
Why?
|
| Leptin | 4 | 2015 | 210 | 0.200 |
Why?
|
| Acyltransferases | 1 | 2022 | 46 | 0.200 |
Why?
|
| Chlorides | 3 | 1998 | 127 | 0.200 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2023 | 388 | 0.200 |
Why?
|
| Amino Acid Transport System y+ | 2 | 2020 | 4 | 0.200 |
Why?
|
| Rheology | 1 | 2022 | 86 | 0.200 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2022 | 237 | 0.200 |
Why?
|
| Biomarkers | 6 | 2022 | 3397 | 0.190 |
Why?
|
| Overnutrition | 1 | 2022 | 30 | 0.190 |
Why?
|
| Up-Regulation | 7 | 2020 | 802 | 0.190 |
Why?
|
| Phosphates | 1 | 2022 | 155 | 0.190 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2016 | 347 | 0.190 |
Why?
|
| Glucose Transport Proteins, Facilitative | 2 | 2014 | 7 | 0.190 |
Why?
|
| Pre-Eclampsia | 1 | 2023 | 166 | 0.180 |
Why?
|
| Esterification | 1 | 2020 | 12 | 0.180 |
Why?
|
| Mice, Obese | 4 | 2022 | 53 | 0.180 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2020 | 22 | 0.180 |
Why?
|
| Serotonin | 2 | 2020 | 292 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2009 | 924 | 0.180 |
Why?
|
| Organogenesis | 1 | 2021 | 55 | 0.180 |
Why?
|
| Embryo, Mammalian | 1 | 2021 | 213 | 0.170 |
Why?
|
| Embryonic and Fetal Development | 1 | 2000 | 94 | 0.170 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2000 | 47 | 0.170 |
Why?
|
| Rats, Wistar | 5 | 2021 | 368 | 0.170 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2016 | 75 | 0.170 |
Why?
|
| Apoptosis | 4 | 2019 | 2349 | 0.170 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2020 | 24 | 0.170 |
Why?
|
| NF-kappa B | 2 | 2014 | 636 | 0.170 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2020 | 55 | 0.170 |
Why?
|
| Developing Countries | 1 | 2021 | 231 | 0.160 |
Why?
|
| Myometrium | 1 | 2019 | 35 | 0.160 |
Why?
|
| Infant, Premature | 2 | 2022 | 478 | 0.160 |
Why?
|
| Apelin | 1 | 2019 | 8 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 10 | 2020 | 4680 | 0.160 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 157 | 0.160 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 2 | 2015 | 34 | 0.160 |
Why?
|
| Olive Oil | 1 | 2018 | 3 | 0.160 |
Why?
|
| PPAR delta | 1 | 2018 | 6 | 0.150 |
Why?
|
| Obstetrics | 2 | 2018 | 146 | 0.150 |
Why?
|
| Cytokines | 2 | 2017 | 1824 | 0.150 |
Why?
|
| Perilipin-2 | 1 | 2018 | 36 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 2 | 2021 | 301 | 0.150 |
Why?
|
| Piperidines | 1 | 2019 | 159 | 0.150 |
Why?
|
| Cohort Studies | 6 | 2022 | 4883 | 0.150 |
Why?
|
| Phthalic Acids | 1 | 2018 | 28 | 0.150 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2015 | 139 | 0.150 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 917 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 787 | 0.140 |
Why?
|
| Specimen Handling | 1 | 2018 | 153 | 0.140 |
Why?
|
| Immunoblotting | 3 | 2003 | 282 | 0.140 |
Why?
|
| Cardiovascular Diseases | 2 | 2022 | 1726 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2015 | 367 | 0.140 |
Why?
|
| Kinetics | 7 | 2000 | 1547 | 0.140 |
Why?
|
| Pregnancy Complications, Parasitic | 1 | 2017 | 9 | 0.140 |
Why?
|
| Transcriptome | 2 | 2022 | 723 | 0.140 |
Why?
|
| DNA Methylation | 2 | 2018 | 493 | 0.140 |
Why?
|
| Malaria, Falciparum | 1 | 2017 | 25 | 0.140 |
Why?
|
| Muscle Contraction | 1 | 2019 | 388 | 0.140 |
Why?
|
| Proteomics | 1 | 2022 | 815 | 0.130 |
Why?
|
| Prenatal Diagnosis | 1 | 2018 | 163 | 0.130 |
Why?
|
| Maternal Exposure | 1 | 2018 | 138 | 0.130 |
Why?
|
| Lysine | 1 | 1998 | 241 | 0.130 |
Why?
|
| Food Deprivation | 1 | 2016 | 24 | 0.130 |
Why?
|
| Liver | 3 | 2023 | 1633 | 0.130 |
Why?
|
| Rats | 10 | 2021 | 4913 | 0.130 |
Why?
|
| RNA Interference | 4 | 2021 | 431 | 0.130 |
Why?
|
| Homeostasis | 1 | 2020 | 570 | 0.130 |
Why?
|
| Regulatory-Associated Protein of mTOR | 4 | 2019 | 17 | 0.130 |
Why?
|
| Heart | 5 | 2019 | 613 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2013 | 399 | 0.130 |
Why?
|
| Biological Transport, Active | 3 | 2015 | 71 | 0.130 |
Why?
|
| beta-Alanine | 3 | 2006 | 17 | 0.130 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 1422 | 0.130 |
Why?
|
| Maternal Age | 3 | 2021 | 116 | 0.130 |
Why?
|
| Altitude | 1 | 2019 | 435 | 0.130 |
Why?
|
| Nanomedicine | 1 | 2016 | 28 | 0.130 |
Why?
|
| Reference Values | 3 | 2002 | 739 | 0.130 |
Why?
|
| Gynecology | 1 | 2018 | 163 | 0.130 |
Why?
|
| Diet | 4 | 2017 | 1080 | 0.130 |
Why?
|
| Glucocorticoids | 1 | 2019 | 526 | 0.120 |
Why?
|
| Epigenesis, Genetic | 2 | 2018 | 518 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2003 | 898 | 0.120 |
Why?
|
| Extracellular Space | 1 | 1995 | 116 | 0.120 |
Why?
|
| Proteome | 1 | 2018 | 337 | 0.120 |
Why?
|
| Adenylate Kinase | 1 | 2014 | 26 | 0.120 |
Why?
|
| Exosomes | 1 | 2016 | 92 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 386 | 0.120 |
Why?
|
| Environmental Exposure | 1 | 2018 | 372 | 0.120 |
Why?
|
| Weight Gain | 2 | 2015 | 453 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 2010 | 3254 | 0.120 |
Why?
|
| Caspase 10 | 1 | 2014 | 5 | 0.120 |
Why?
|
| Caloric Restriction | 1 | 2015 | 89 | 0.120 |
Why?
|
| Chorionic Gonadotropin | 1 | 2014 | 78 | 0.120 |
Why?
|
| Models, Biological | 3 | 2019 | 1611 | 0.110 |
Why?
|
| Cell Survival | 3 | 2012 | 1014 | 0.110 |
Why?
|
| Mitochondria | 2 | 2019 | 744 | 0.110 |
Why?
|
| Membrane Potentials | 6 | 2003 | 247 | 0.110 |
Why?
|
| Adenosine Triphosphate | 2 | 2006 | 428 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 990 | 0.110 |
Why?
|
| Caspase 1 | 1 | 2014 | 140 | 0.110 |
Why?
|
| Fetal Diseases | 1 | 2015 | 146 | 0.110 |
Why?
|
| Immune System | 1 | 2015 | 171 | 0.110 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2013 | 24 | 0.110 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2013 | 12 | 0.110 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2013 | 9 | 0.110 |
Why?
|
| Infant, Low Birth Weight | 3 | 2019 | 124 | 0.110 |
Why?
|
| Ubiquitination | 3 | 2022 | 86 | 0.110 |
Why?
|
| Caspase 3 | 1 | 2014 | 234 | 0.110 |
Why?
|
| Vitamin D | 1 | 2016 | 340 | 0.110 |
Why?
|
| Oxidoreductases | 1 | 2014 | 89 | 0.110 |
Why?
|
| Incidence | 1 | 2019 | 2314 | 0.110 |
Why?
|
| Disease Models, Animal | 6 | 2022 | 3498 | 0.110 |
Why?
|
| Infant | 3 | 2023 | 7943 | 0.110 |
Why?
|
| Nutritional Status | 1 | 2015 | 286 | 0.110 |
Why?
|
| Dietary Fats | 3 | 2011 | 287 | 0.100 |
Why?
|
| C-Reactive Protein | 1 | 2015 | 362 | 0.100 |
Why?
|
| Adaptation, Physiological | 1 | 2016 | 484 | 0.100 |
Why?
|
| Gene Expression | 2 | 2009 | 1417 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 167 | 0.100 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 3 | 2019 | 28 | 0.100 |
Why?
|
| Brain | 1 | 2023 | 2355 | 0.100 |
Why?
|
| Diet, High-Fat | 3 | 2022 | 225 | 0.100 |
Why?
|
| Dyslipidemias | 1 | 2013 | 153 | 0.100 |
Why?
|
| Nedd4 Ubiquitin Protein Ligases | 3 | 2016 | 13 | 0.100 |
Why?
|
| Hydrops Fetalis | 1 | 1991 | 13 | 0.100 |
Why?
|
| Polyhydramnios | 1 | 1991 | 16 | 0.100 |
Why?
|
| Lactates | 1 | 1991 | 78 | 0.100 |
Why?
|
| Mass Screening | 1 | 2018 | 979 | 0.090 |
Why?
|
| Lactic Acid | 3 | 2006 | 272 | 0.090 |
Why?
|
| Glucose Tolerance Test | 2 | 2022 | 343 | 0.090 |
Why?
|
| Biological Availability | 2 | 2023 | 119 | 0.090 |
Why?
|
| Cell Membrane Permeability | 3 | 1999 | 83 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 1168 | 0.090 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 1175 | 0.080 |
Why?
|
| Dietary Proteins | 1 | 2011 | 121 | 0.080 |
Why?
|
| Adolescent | 3 | 2019 | 17800 | 0.080 |
Why?
|
| Nickel | 2 | 2003 | 50 | 0.080 |
Why?
|
| Sirolimus | 4 | 2018 | 181 | 0.080 |
Why?
|
| Osmolar Concentration | 4 | 2004 | 169 | 0.080 |
Why?
|
| Proteolysis | 2 | 2022 | 142 | 0.080 |
Why?
|
| Spleen | 1 | 2010 | 485 | 0.070 |
Why?
|
| Protein Transport | 3 | 2015 | 391 | 0.070 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenases | 1 | 2007 | 3 | 0.070 |
Why?
|
| Oxidative Stress | 2 | 2018 | 1068 | 0.070 |
Why?
|
| Food | 1 | 2009 | 160 | 0.070 |
Why?
|
| Amino Acid Transport Systems, Neutral | 1 | 2007 | 3 | 0.070 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2007 | 27 | 0.070 |
Why?
|
| Health Status | 1 | 2011 | 716 | 0.070 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2018 | 160 | 0.070 |
Why?
|
| Guinea Pigs | 4 | 1995 | 136 | 0.070 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2006 | 20 | 0.070 |
Why?
|
| Uridine Triphosphate | 1 | 2006 | 11 | 0.070 |
Why?
|
| Muscle Proteins | 2 | 2006 | 210 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2022 | 4402 | 0.070 |
Why?
|
| Membrane Glycoproteins | 2 | 2008 | 429 | 0.070 |
Why?
|
| Water | 2 | 1999 | 394 | 0.060 |
Why?
|
| Societies, Scientific | 1 | 2006 | 47 | 0.060 |
Why?
|
| Energy Intake | 1 | 2008 | 427 | 0.060 |
Why?
|
| Awards and Prizes | 1 | 2006 | 56 | 0.060 |
Why?
|
| Sodium-Calcium Exchanger | 2 | 1995 | 13 | 0.060 |
Why?
|
| Hydrocortisone | 1 | 2006 | 267 | 0.060 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 341 | 0.060 |
Why?
|
| Child Development | 2 | 2017 | 384 | 0.060 |
Why?
|
| Fluorescent Dyes | 1 | 2006 | 298 | 0.060 |
Why?
|
| Calcium Signaling | 1 | 2006 | 213 | 0.060 |
Why?
|
| Amino Acids, Essential | 1 | 2023 | 12 | 0.060 |
Why?
|
| Sheep | 2 | 2020 | 761 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 315 | 0.060 |
Why?
|
| Hyperglycemia | 1 | 2007 | 292 | 0.050 |
Why?
|
| Cytophotometry | 1 | 2003 | 1 | 0.050 |
Why?
|
| Fluorometry | 1 | 2003 | 19 | 0.050 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2003 | 21 | 0.050 |
Why?
|
| Stimulation, Chemical | 1 | 2003 | 55 | 0.050 |
Why?
|
| Electrolytes | 1 | 2003 | 55 | 0.050 |
Why?
|
| Estradiol | 1 | 2006 | 450 | 0.050 |
Why?
|
| Epithelium | 1 | 2004 | 295 | 0.050 |
Why?
|
| Cobalt | 1 | 2003 | 43 | 0.050 |
Why?
|
| Computer Systems | 1 | 2003 | 46 | 0.050 |
Why?
|
| Diglycerides | 1 | 2003 | 53 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2021 | 6195 | 0.050 |
Why?
|
| Umbilical Veins | 2 | 2014 | 57 | 0.050 |
Why?
|
| Membrane Fluidity | 2 | 1999 | 10 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2002 | 193 | 0.050 |
Why?
|
| Mannitol | 2 | 1999 | 32 | 0.050 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2022 | 14 | 0.050 |
Why?
|
| Pregnancy, High-Risk | 1 | 2002 | 12 | 0.050 |
Why?
|
| Cholesterol | 3 | 1999 | 368 | 0.050 |
Why?
|
| Middle Aged | 2 | 2019 | 26605 | 0.050 |
Why?
|
| Urea | 2 | 1999 | 66 | 0.050 |
Why?
|
| Adult Children | 1 | 2022 | 21 | 0.050 |
Why?
|
| Time Factors | 3 | 2008 | 6077 | 0.050 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2023 | 100 | 0.050 |
Why?
|
| DNA Primers | 1 | 2003 | 508 | 0.050 |
Why?
|
| Fetal Heart | 1 | 2022 | 37 | 0.050 |
Why?
|
| 3T3-L1 Cells | 1 | 2022 | 31 | 0.050 |
Why?
|
| Carnitine | 1 | 2022 | 62 | 0.050 |
Why?
|
| ortho-Aminobenzoates | 2 | 1998 | 7 | 0.050 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 2 | 1998 | 12 | 0.050 |
Why?
|
| Inflammation Mediators | 2 | 2015 | 475 | 0.050 |
Why?
|
| Norway | 1 | 2021 | 36 | 0.050 |
Why?
|
| Intra-Abdominal Fat | 1 | 2022 | 77 | 0.050 |
Why?
|
| Cardiomegaly | 1 | 2022 | 158 | 0.050 |
Why?
|
| Parity | 1 | 2021 | 97 | 0.050 |
Why?
|
| Fusion Regulatory Protein 1, Heavy Chain | 1 | 2020 | 1 | 0.050 |
Why?
|
| Monoamine Oxidase | 1 | 2020 | 27 | 0.050 |
Why?
|
| Adenylyl Cyclases | 1 | 2001 | 83 | 0.040 |
Why?
|
| Vitrification | 1 | 2020 | 6 | 0.040 |
Why?
|
| Cystic Fibrosis | 1 | 2010 | 955 | 0.040 |
Why?
|
| Mothers | 2 | 2017 | 650 | 0.040 |
Why?
|
| Ouabain | 1 | 2000 | 15 | 0.040 |
Why?
|
| Birth Rate | 1 | 2020 | 19 | 0.040 |
Why?
|
| Embryo Implantation | 1 | 2020 | 23 | 0.040 |
Why?
|
| Blastocyst | 1 | 2020 | 44 | 0.040 |
Why?
|
| Immune Sera | 1 | 2000 | 79 | 0.040 |
Why?
|
| Umbilical Cord | 1 | 2020 | 80 | 0.040 |
Why?
|
| Embryo Transfer | 1 | 2020 | 29 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 328 | 0.040 |
Why?
|
| Adipocytes | 1 | 2022 | 188 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 2000 | 192 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 2001 | 142 | 0.040 |
Why?
|
| Protein Kinase C | 2 | 2004 | 271 | 0.040 |
Why?
|
| Duodenum | 1 | 2000 | 62 | 0.040 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 79 | 0.040 |
Why?
|
| Heart Ventricles | 2 | 1995 | 723 | 0.040 |
Why?
|
| Choline | 1 | 2000 | 106 | 0.040 |
Why?
|
| Receptor, Insulin | 1 | 2019 | 93 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2000 | 283 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2000 | 507 | 0.040 |
Why?
|
| Apelin Receptors | 1 | 2019 | 3 | 0.040 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2019 | 25 | 0.040 |
Why?
|
| Organelle Biogenesis | 1 | 2019 | 14 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2020 | 152 | 0.040 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2019 | 84 | 0.040 |
Why?
|
| Health Status Indicators | 1 | 2000 | 155 | 0.040 |
Why?
|
| Membrane Lipids | 1 | 1999 | 87 | 0.040 |
Why?
|
| Electron Transport | 1 | 2019 | 108 | 0.040 |
Why?
|
| Protein Interaction Maps | 1 | 2018 | 35 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 241 | 0.040 |
Why?
|
| Tetrahydrofolates | 1 | 2018 | 11 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2019 | 130 | 0.040 |
Why?
|
| Mitosis | 1 | 2019 | 164 | 0.040 |
Why?
|
| Environmental Health | 1 | 2018 | 30 | 0.040 |
Why?
|
| Taurine | 1 | 1998 | 41 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 154 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2020 | 326 | 0.040 |
Why?
|
| Phenotype | 1 | 2005 | 2784 | 0.040 |
Why?
|
| Uterus | 1 | 2019 | 191 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 1998 | 113 | 0.040 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2000 | 176 | 0.040 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2017 | 26 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2017 | 108 | 0.030 |
Why?
|
| Phosphoproteins | 2 | 2011 | 293 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2017 | 75 | 0.030 |
Why?
|
| Homocysteine | 1 | 2017 | 137 | 0.030 |
Why?
|
| Receptors, Calcitriol | 1 | 2016 | 53 | 0.030 |
Why?
|
| Cholecalciferol | 1 | 2016 | 47 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 777 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 569 | 0.030 |
Why?
|
| Glucose Transporter Type 3 | 2 | 2007 | 11 | 0.030 |
Why?
|
| Temperature | 3 | 1993 | 564 | 0.030 |
Why?
|
| Amino Acid Transport System y+L | 1 | 2015 | 4 | 0.030 |
Why?
|
| Fatty Acid Binding Protein 3 | 1 | 2015 | 4 | 0.030 |
Why?
|
| Membranes | 1 | 1995 | 18 | 0.030 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2015 | 12 | 0.030 |
Why?
|
| Xenobiotics | 1 | 2016 | 24 | 0.030 |
Why?
|
| Sarcolemma | 1 | 1995 | 29 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2016 | 171 | 0.030 |
Why?
|
| Excitatory Amino Acids | 1 | 2015 | 7 | 0.030 |
Why?
|
| Transport Vesicles | 1 | 2015 | 18 | 0.030 |
Why?
|
| Dietary Sucrose | 1 | 2015 | 45 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2015 | 139 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 205 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2015 | 133 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 2629 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 92 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2017 | 337 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 1996 | 393 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 1995 | 239 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2018 | 545 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2017 | 366 | 0.030 |
Why?
|
| Ventricular Function | 3 | 1987 | 57 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2020 | 1696 | 0.030 |
Why?
|
| Transfection | 1 | 2015 | 863 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 2004 | 408 | 0.030 |
Why?
|
| Photolysis | 1 | 1993 | 79 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 1080 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2022 | 1468 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 1993 | 108 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 1656 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2013 | 200 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 2700 | 0.030 |
Why?
|
| Models, Cardiovascular | 1 | 1993 | 179 | 0.030 |
Why?
|
| Perfusion | 2 | 2004 | 147 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 4392 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2019 | 2173 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2007 | 2182 | 0.020 |
Why?
|
| Bicarbonates | 1 | 1991 | 41 | 0.020 |
Why?
|
| Blood Volume | 1 | 1991 | 57 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 3315 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 970 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2011 | 21 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2015 | 727 | 0.020 |
Why?
|
| Ion Channels | 2 | 1988 | 121 | 0.020 |
Why?
|
| Peptides | 1 | 1995 | 847 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 1836 | 0.020 |
Why?
|
| Xanthines | 1 | 1990 | 15 | 0.020 |
Why?
|
| Carbamazepine | 1 | 1990 | 18 | 0.020 |
Why?
|
| Receptors, Adrenergic | 1 | 1990 | 35 | 0.020 |
Why?
|
| Women's Health | 1 | 2011 | 270 | 0.020 |
Why?
|
| Stem Cells | 1 | 2013 | 541 | 0.020 |
Why?
|
| Purines | 1 | 1990 | 158 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2010 | 471 | 0.020 |
Why?
|
| Colforsin | 1 | 1988 | 47 | 0.020 |
Why?
|
| Adenosine | 1 | 1990 | 203 | 0.020 |
Why?
|
| Isoproterenol | 1 | 1988 | 105 | 0.020 |
Why?
|
| Body Weight | 1 | 2012 | 868 | 0.020 |
Why?
|
| Action Potentials | 3 | 1988 | 406 | 0.020 |
Why?
|
| Carbon Radioisotopes | 1 | 2006 | 36 | 0.020 |
Why?
|
| Sulfonamides | 1 | 1990 | 444 | 0.020 |
Why?
|
| Tetrodotoxin | 2 | 1987 | 39 | 0.020 |
Why?
|
| Amniotic Fluid | 1 | 2006 | 64 | 0.020 |
Why?
|
| Protons | 1 | 2006 | 73 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 1987 | 318 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2011 | 582 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2008 | 575 | 0.020 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2004 | 36 | 0.010 |
Why?
|
| Sex Factors | 1 | 2010 | 1706 | 0.010 |
Why?
|
| Phosphofructokinases | 1 | 2004 | 1 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2004 | 192 | 0.010 |
Why?
|
| Hexokinase | 1 | 2004 | 10 | 0.010 |
Why?
|
| Pyruvate Kinase | 1 | 2004 | 19 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2017 | 9114 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 549 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2003 | 107 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 2537 | 0.010 |
Why?
|
| Methods | 1 | 1981 | 57 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 1981 | 88 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2007 | 946 | 0.010 |
Why?
|
| Sodium-Hydrogen Exchanger 3 | 1 | 2000 | 1 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 527 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 1471 | 0.010 |
Why?
|
| Cell Separation | 1 | 1981 | 290 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2004 | 641 | 0.010 |
Why?
|
| Wales | 1 | 2000 | 16 | 0.010 |
Why?
|
| Database Management Systems | 1 | 2000 | 47 | 0.010 |
Why?
|
| Medical Audit | 1 | 2000 | 75 | 0.010 |
Why?
|
| Disabled Children | 1 | 2000 | 69 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 3039 | 0.010 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 1998 | 2 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1998 | 48 | 0.010 |
Why?
|
| Antiporters | 1 | 1998 | 18 | 0.010 |
Why?
|
| Cyclic AMP | 2 | 1990 | 225 | 0.010 |
Why?
|
| Filtration | 1 | 1998 | 57 | 0.010 |
Why?
|
| Data Collection | 1 | 2000 | 618 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1998 | 296 | 0.010 |
Why?
|
| Scattering, Radiation | 1 | 1993 | 94 | 0.010 |
Why?
|
| Lipid Bilayers | 1 | 1993 | 94 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2000 | 1381 | 0.010 |
Why?
|
| Thermodynamics | 1 | 1993 | 380 | 0.010 |
Why?
|
| Light | 1 | 1993 | 336 | 0.010 |
Why?
|
| Phenylisopropyladenosine | 1 | 1990 | 5 | 0.010 |
Why?
|
| Adenosine-5'-(N-ethylcarboxamide) | 1 | 1990 | 9 | 0.010 |
Why?
|
| Clonidine | 1 | 1990 | 22 | 0.010 |
Why?
|
| Theophylline | 1 | 1990 | 60 | 0.010 |
Why?
|
| Caffeine | 1 | 1990 | 56 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1990 | 114 | 0.010 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1988 | 24 | 0.000 |
Why?
|
| Metoprolol | 1 | 1988 | 37 | 0.000 |
Why?
|
| Ryanodine | 1 | 1987 | 13 | 0.000 |
Why?
|
| Albuterol | 1 | 1988 | 102 | 0.000 |
Why?
|
| Egtazic Acid | 1 | 1987 | 40 | 0.000 |
Why?
|
| Nifedipine | 1 | 1987 | 29 | 0.000 |
Why?
|
| Acetylcholine | 1 | 1988 | 166 | 0.000 |
Why?
|
| Behavior, Animal | 1 | 1990 | 459 | 0.000 |
Why?
|
| Motor Activity | 1 | 1990 | 635 | 0.000 |
Why?
|